ABHI LEADERSHIP
Ways Early Cancer Detection and Diagnosis Can Improve Healthcare
Nishan Sunthares Managing Director, Diagnostics, ABHI
It is beyond doubt that cancer detected at an early stage saves lives. If diagnosed at the earliest stage, almost all women with breast cancer and more than 9 in 10 people with bowel cancer survive their disease for five years or more. This falls to around 3 in 10 women when breast cancer is diagnosed at the most advanced stage and drops to just 1 in 10 people for those with bowel cancer. Ambitious targets, such as NHS England’s commitment to detecting
75% of cancers at stage I and II by 2028, have improved public awareness. Additionally, more streamlined diagnostic pathways all contribute to shifting our ability to accurately detect and diagnose cancer at an early stage. Yet, the true potential of early detection and diagnosis remains largely unexploited. Multi-cancer early detection (MCED) tests have the potential to find more than one type of cancer from a single blood sample and revolutionise cancer screening. Investment in and research into the effectiveness of MCEDs continues apace. As the amount of data generated from an individual’s healthcare journey
increases, the application of artificial intelligence (AI) is expanding to determine new approaches for cancer detection, screening and diagnosis. AI tools enable the incorporation and computational analysis of disparate, complex data streams to inform predictive treatment models, rendering possible precision oncology and personalised medicine. At a molecular level, advances in genome sequencing provide evidence of
genetic mutations which might predispose a patient to cancer. A route to risk- based detection and prevention is starting to emerge to support a life course approach to minimising risk factors and enhancing protective factors through evidence-based interventions at important life stages. Beyond the clear potential for health benefits, a shift to early diagnosis
can alleviate the need for costly, long-term treatments, thus aiding the clinical workforce and easing pressures on the healthcare system itself. The UK can be a world leader in developing a thriving early detection and diagnosis industry, capitalising on its excellent science base, the unmatched diversity of health data and infrastructure and a history of collaborative efforts across an interlinked network of expertise.
MEDICA 2023 UKHEALTHCARE P A VILION. COM 25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
